Seer, Inc.
Seer, Inc. (SEER) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SEER · as of Jun 9, 2026
Key Statistics
Explore Seer, Inc. Data
seer stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 25.0%
The SEER analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +123.55% upside from the current price of $1.79.
Competitors & Peers
seer competitorsSEER
ANEB
ANTX
CCCC
CGEM
FHTXStock Performance
Full HistoryAbout Seer, Inc.
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteo…
what is seer, inc. · seer stock overview · seer, inc. company profile · who is seer, inc. ceo · seer NASDAQ · seer, inc. headquarters · seer, inc. business segments
About Stock Overview & Key Data
Seer, Inc. (SEER) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 4, 2020. As of the latest trading session, SEER stock price is $1.79, with a market capitalization of $98.4M. The stock has returned -18.86% over the past 12 months and -2.46% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Seer, Inc. stock is Hold, with an average 12-month price target of $4.00. In fiscal year 2025, Seer, Inc. reported revenue of $16.1M and net income of -$73.6M. For detailed data — including Seer, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Seer, Inc. (SEER) stock price is $1.79. The stock is traded on NASDAQ under the ticker symbol SEER. The 52-week range is $1.65 – $2.41.